What changed
Field-level changes across 12 tracked APOE-directed therapeutics — registry edits, SEC filing diffs, label revisions and new publications. 0 of the 230 changes in this snapshot are high-significance. Every row links to the record it was read from.
1 source is not reporting cleanly — changes may be missingeuropepmc STALE
Changes that would have come from the sources below are absent from this feed. Absence here means “not observed”, not “did not happen”.
- Europe PMC (
europepmc, daily) — last successful fetch (2 days ago), last run statusok— past its staleness threshold.
230 changes detected between and (most recent 2 days ago). Newest first.
Significance
PENSA+: Extended Follow-up of a Multimodal Lifestyle Intervention to Prevent Cognitive Decline in APOE-ε4 Carriers
new study registeredNCT07730671A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
new study registeredNCT07688213ALZEVIT: Nationwide Digital APOE ε4 Cohort for Early Alzheimer's Disease Prevention and Trial Readiness
new study registeredNCT07679906Digital Lifestyle Coaching for Alzheimer's Disease Prevention in APOE4 Carriers
new study registeredNCT07646054China-NINE Cohort：Neuroimmune Network in Elderly / Neurodegeneration
new study registeredNCT07586501Predicting Pre-dementia
new study registeredNCT07516119Art of Memory for Cognitive Enhancement in the Monza Brain Health Service
new study registeredNCT07479914Levetiracetam for Persons at Risk for Alzheimer's Disease
new study registeredNCT07477431Lombard Cohort of Brain Health Services
new study registeredNCT07457138Making Antibody Treatments More Effective in Early Alzheimer's Disease Using 3Tesla Magnetica Resonance
new study registeredNCT07456462The Signature of Alzheimer's Disease in Subjective Cognitive Decline
new study registeredNCT07402161Study to Evaluate the Effect of HT-4253 for the Prevention of Alzheimer's Disease in APOE4 Carriers
new study registeredNCT07399171CLarifying ABCB1's Role in Alzheimer's Disease
new study registeredNCT07393113ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults
new study registeredNCT07392723A Study of Retinal Imaging to Detect Abnormal Protein Deposits Associated With Alzheimer's Disease
new study registeredNCT07254234Research Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM Device
new study registeredNCT07222605The Purpose of This Study is to Evaluate the Safety and Tolerability of X/T+X-EC in Participants With Alzheimer's Disease Who Are Currently Treated With Lecanemab.
new study registeredNCT07212062Intravenous Infusion of Umbilical Cord Blood as an Adjunctive Treatment for Alzheimer's Disease
new study registeredNCT07208344TSPO Modulation in AD
new study registeredNCT07191821Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases
new study registeredNCT0704934112-Month Real-World Safety & Efficacy of Lecanemab in Early Alzheimer's Disease
new study registeredNCT07034222Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease
new study registeredNCT07027072Biomarkers of the Locus Coeruleus Nucleus: Links With Early Tau Pathology, Cognition and Alzheimer's Disease Risk
new study registeredNCT07007208A Study of Donanemab, RG6289, or the Combination of Donanemab and RG6289 in Presenilin 1 (PSEN1) E280A Mutation Carriers for the Treatment of Autosomal-Dominant Alzheimer's Disease
new study registeredNCT06996730A Study to Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate Alzheimer's Disease
new study registeredNCT06995573Near-Infrared Light Therapy Combined With Lecanemab for Mild Alzheimer's Disease
new study registeredNCT06992804Alzheimer's Tau Platform: Master Protocol
new study registeredNCT06957418Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation
new study registeredNCT06911944An Innovative Method in SAliva Samples for the Early Differential Diagnosis of High-impact NeuroDegenerative Diseases Through Raman Spectroscopy
new study registeredNCT06875739Study to Detect Dendritic Cell Recruitment in Human Retina
new study registeredNCT06872658Clinical Utility of Early vs. Late Blood Biomarker Testing for Alzheimer's Disease
new study registeredNCT06856681The Role of Advanced Electroencephalographic Data as Marker of Pathology and Prognosis in Primary Dementias
new study registeredNCT06826157Stem Cell Therapy for Early Alzheimer's Disease
new study registeredNCT06775964Prospective Cohort Study of Patients With Early Alzheimer's Disease Treated With Lecanemab
new study registeredNCT06741553A Nutritional Intervention for Body, Brain, and Longevity Effects (NIBBLE)
new study registeredNCT06682767Understanding Cerebral Blood Flow Dynamics for Alzheimer's Disease Prevention Through Exercise
new study registeredNCT06584656A Study of AMDX-2011P in Participants With Alzheimer's Disease
new study registeredNCT06514001A Clinical Trial to Evaluate the Initial Safety and Efficacy of Repetitive BBB (Blood Brain Barrier) Disruption Using High Intensity Focused Ultrasound 'ExAblate 4000 Type 2.1' in Patients With Alzheimer's Disease
new study registeredNCT06474013Evaluation of Self-Mediated Alternatives for Risk Testing Education and Return of Results
new study registeredNCT06459583Clinical Evaluation of Acupuncture Treatment on Alzheimer's Disease in APOE e4 Carriers and Non-Carriers
new study registeredNCT06417086Alzheimer's Plasma Extension
new study registeredNCT06416072The Effects of Social Isolation and Social Interaction on the Risk of Dementia Progression and Brain Function in SCD (Subjective Cognitive Decline, SCD)
new study registeredNCT06335836A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)
new study registeredNCT06335173Polymorphism of ApoE in Alzheimer's Disease: Genetic Study in Castile and Leon (Spain)
new study registeredNCT06275243Detecting an MCI and Amyloid Digital Neuro Signature(DNS) Using Altoida's Multimodal Digital Biomarkers.
new study registeredNCT06223438Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients
new study registeredNCT06199037Greater-Bay-Area Healthy Aging Brain Study (GHABS)
new study registeredNCT06183658Study of N-homocysteinylation of Key Proteins in Alzheimer's Disease (HO-MA)
new study registeredNCT06168955Repetitive Blood Brain Barrier Opening for Alzheimer's Disease.
new study registeredNCT06158789The Swedish BioFINDER - Preclinical AD Study
new study registeredNCT06121544Bumetanide in Patients With Alzheimer's Disease
new study registeredNCT06052163A Community-Based Screening Program to Identify Participants at High Risk for Amyloid Pathology
new study registeredNCT06043700Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry
new study registeredNCT05999084Targeting Default Mode Network Dysfunction in Persons At Risk of Alzheimer's Disease with Non-invasive Techniques
new study registeredNCT05984446Safety and Pharmacokinetics of Single Ascending Doses and Multiple Ascending Doses of CS6253 in Healthy Volunteers
new study registeredNCT05965414Exploring to Remediate Behavioral Disturbances of Spatial Cognition
new study registeredNCT05944601Does EVOO Induce Gene and Metabolic Changes in Healthy Subjects
new study registeredNCT05929924Cognitive Neurology Unit Clinical Registry
new study registeredNCT05925621DIetary plAnt Extracts, Colonic MicrObes, and Apoe geNetics Interactions stuDy
new study registeredNCT05905822Choline Effects - Pre-symptomatic AD
new study registeredNCT05880849Tricaprilin Phase 3 ALTER-AD (Alternative-Alzheimer Disease) Study
new study registeredNCT05809908Hyperhomocysteinemia in Alzheimer's Disease
new study registeredNCT05793372A Study of SHR-1707 With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
new study registeredNCT05681819Cognitive Impairment Cohort Study of the Elderly Population in SheMountain
new study registeredNCT05667935Sleep Impairment in Subjects at Risk of Developing Alzheimer's Disease
new study registeredNCT05649514Alzheimer's Disease Neuroimaging Initiative 4
new study registeredNCT05617014Health Behavior Change in Midlife Adults at Risk for Alzheimer's Disease
new study registeredNCT05599425Acute Exercise on Neurocognitive Function Among Adults With/Without Generic Risk of AD
new study registeredNCT05591313PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer's Disease With Machine Learning
new study registeredNCT05569083A First in Human Study of IBC-Ab002 in Persons With Early Alzheimer's Disease (AD)
new study registeredNCT05551741Clinical Trial on Agitation in Alzheimer's Dementia
new study registeredNCT05543681Community-based Brain Health Program to Address Dementia Risk
new study registeredNCT05529706Dynamic Response to Probiotics in Context of Alzheimer Disease: a Proof-of-concept Study
new study registeredNCT05521477BioFINDER-Brown: Examination of Alzheimer's Disease Biomarkers
new study registeredNCT05457998Evaluating the Efficacy of Artificial Intelligence-based Computer Aided Diagnosis Software That Assists in Determining Whether or Not to Conduct Amyloid PET for the Diagnosis of Alzheimer's Disease by Predicting Amyloid PET Positivity in Mild Cognitive Impairment Patients
new study registeredNCT05383053Vanderbilt Memory and Aging Project
new study registeredNCT05372159Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation
new study registeredNCT05321498A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
new study registeredNCT05310071Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease
new study registeredNCT05267535Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
new study registeredNCT05245903Triglyceride Effects on Blood Flow in the Human Brain
new study registeredNCT05218018Proof-of-concept, Open-label Study in Patients With Early Alzheimer's Disease
new study registeredNCT05161715The STEP 4Life Trial
new study registeredNCT05069155The Use of Memantine for Prevention of Alzheimer's Disease
new study registeredNCT05063851Aβ Dynamics in LLMD
new study registeredNCT05004987Investigating the Impact of Alzheimer's Disease Diagnostics in British Columbia
new study registeredNCT05002699APOE in the Predisposition to, Protection From, and Prevention of Alzheimer's Disease
new study registeredNCT04994847Development of an EEG Diagnostic for Alzheimer's Disease
new study registeredNCT04954183A Study to Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild AD
new study registeredNCT04931459CYCLE-AD (CYcling to Cease or Limit the Effects of Alzheimer's Disease)
new study registeredNCT04748861Pilot Clinical Study of CT1812 in Mild to Moderate Alzheimer's Disease Using EEG
new study registeredNCT04735536Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413)
new study registeredNCT04730635Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies
new study registeredNCT04699786Apolipoprotein E (APOE) Genotype Effects on Triglycerides and Blood Flow in the Human Brain
new study registeredNCT04692441A Phase 3 Study of NE3107 in Probable Alzheimer's Disease
new study registeredNCT04669028Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease
new study registeredNCT04639050Multimodal Biomarkers for Diagnosis and Prognosis in VCI
new study registeredNCT04604600Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)
new study registeredNCT04601038A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease
new study registeredNCT04592874Study on Biomarkers for Early Diagnosis of Alzheimer's Disease
new study registeredNCT04575337Randomized I/II Phase Study of ALZT-OP1 Combination Therapy in Alzheimer's Disease and Normal Healthy Volunteers
new study registeredNCT04570644Assessment of Initial Efficacy and Safety of High Intensity Focused Ultrasound 'ExAblate 4000 Type 2' for Blood Brain Barrier Disruption in Patients With Alzheimer's Disease
new study registeredNCT04526262Information About Alzheimer's Disease for Latinos in New York City
new study registeredNCT04471779Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia
new study registeredNCT04430517New IDEAS: Imaging Dementia-Evidence for Amyloid Scanning Study
new study registeredNCT04426539To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD Dementia
new study registeredNCT04311515The Influence of Vascular Burden, Amyloid Plaque and Tau Protein in Patients With Vascular Cognitive Impairment and Dementia With Tauopathy
new study registeredNCT04309253A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension
new study registeredNCT04187547Monitoring Anti-Dementia Drugs by Serum Levels
new study registeredNCT04117178Hearing Aid and Individuals With Cognitive Disorders
new study registeredNCT04049643MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients
new study registeredNCT04032626Modulation of Cognition and Brain Connectivity by Noninvasive Brain Stimulation in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease
new study registeredNCT04012346Dementia Risk and Dynamic Response to Exercise
new study registeredNCT04009629Prevention of Cognitive Decline in ApoE4 Carriers With Subjective Cognitive Decline After EGCG and a Multimodal Intervention
new study registeredNCT03978052Multimodal Biomarkers for Diagnosis and Prognosis in CAA
new study registeredNCT03969732A Biomarker-directed Study of XPro1595 in Patients With Alzheimer's
new study registeredNCT03943264Brain Energy Metabolism and Sleep in Adults
new study registeredNCT03929302Epileptiform Activity During REM Sleep in Alzheimer's Disease
new study registeredNCT03923569Physical Activity, Alzheimer's Disease and Cognition Relative to APOE Genotype
new study registeredNCT03876314Atlas of Retinal Imaging in Alzheimer's Study
new study registeredNCT03862222BarcelonaBeta Dementia Prevention Research Clinic: a Study on Risk Factors Disclosure
new study registeredNCT03847038Imaging of Brain Structural/Functional Connectivity and Amyloid and Tau Lesions in APOE4 Carriers.
new study registeredNCT03816228Genetic Information as a Life Style Change Motivator
new study registeredNCT03794141ExAblate Blood-Brain Barrier Opening for Treatment of Alzheimer's Disease
new study registeredNCT03739905Exercise for Brain Health in the Fight Against Alzheimer's Disease
new study registeredNCT03727360Efavirenz for Patients With Alzheimer's Disease
new study registeredNCT03706885ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease
new study registeredNCT03671889Sustainable Method for Alzheimer's Prediction
new study registeredNCT03654911China Cognition and Aging Study
new study registeredNCT03653156A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities
new study registeredNCT03639987DHA Brain Delivery Trial
new study registeredNCT03613844Stimulating Neural Activity to Improve Blood Flow and Reduce Amyloid: Path to Clinical Trials
new study registeredNCT03543878Study to Evaluate the Effect of CT1812 Treatment on Amyloid Beta Oligomer Displacement Into CSF in Subjects With Mild to Moderate Alzheimer's Disease
new study registeredNCT03522129Effect of CT1812 Treatment on Brain Synaptic Density
new study registeredNCT03493282Enriching Clinical Trials Requiring Amyloid Positivity With Practice Effects
new study registeredNCT03466736Network-Level Mechanisms for Preclinical Alzheimer's Disease Development
new study registeredNCT03461861Ectosomes, New Biomarkers of Tau Pathology?
new study registeredNCT03381482Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease
new study registeredNCT03352557Response to Donepezil, Drug Plasma Concentration and the CYP2D6 and APOE Genetic Polymorphisms
new study registeredNCT03349320Retinal Imaging in Neurodegenerative Disease
new study registeredNCT03233646A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
new study registeredNCT03131453A Phase I [18F]THK-5351 Positron Emission Tomography Study in Healthy Subjects and Alzheimer's Disease
new study registeredNCT03112096S-Equol in Alzheimer's Disease 2 Trial
new study registeredNCT03101085APOE Genotype and Diet Influences on Alzheimer's Biomarkers
new study registeredNCT03070535Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
new study registeredNCT03019757Multiple Dose Safety Study of NPT088 in Patients With Mild to Moderate Probable Alzheimer's Disease
new study registeredNCT03008161Feasibility and Effects of Valaciclovir Treatment in Persons With Early Alzheimer's Disease
new study registeredNCT02997982Telephone Versus Videoconference Communication for Remote Genetic Disclosure in the APOE4 Trial
new study registeredNCT02978729Risk Evaluation and Education for Alzheimer's Disease - the Study of Communicating Amyloid Neuroimaging (REVEAL-SCAN)
new study registeredNCT02959489Alzheimer's Disease Neuroimaging Initiative 3
new study registeredNCT02854033Cognitive, Morphological and Neurobiological Progressive Aspects in Bipolar Disorders in the Elderly: Toward to a Neurodegenerescence Detection?
new study registeredNCT02843906Implications for Management of PET Amyloid Classification Technology in the Imaging Dementia(IDEAS) Trial
new study registeredNCT02781220Implications for Management of PET Amyloid Classification Technology
new study registeredNCT02778971Safety and Efficacy of Suvorexant (MK-4305) for the Treatment of Insomnia in Participants With Alzheimer's Disease (MK-4305-061)
new study registeredNCT02750306Dosage and Efficacy of Probucol-induced apoE to Negate Cognitive Deterioration
new study registeredNCT02707458[18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease
new study registeredNCT02656498An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
new study registeredNCT02569398A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
new study registeredNCT02565511GeneMatch: A Program of the Alzheimer's Prevention Registry to Match Individuals to Studies Based on Apolipoprotein E (APOE) Genotype
new study registeredNCT02564692Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease
new study registeredNCT02547818BEAM: Brain-Eye Amyloid Memory Study
new study registeredNCT02524405Dietary Treatments for Cognitive Impairment in Older Adults
new study registeredNCT02521818221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
new study registeredNCT02484547221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
new study registeredNCT02477800Brain Sleep Clearance of Amyloid-Beta Peptides
new study registeredNCT02474251Macronutrient Effects on Alzheimer's Disease (MEAL-2)
new study registeredNCT02463084Intermittent Calorie Restriction, Insulin Resistance, and Biomarkers of Brain Function
new study registeredNCT02460783Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study
new study registeredNCT02420756Benfotiamine in Alzheimer's Disease: A Pilot Study
new study registeredNCT02292238ATP in Alzheimer Disease
new study registeredNCT02279511Apoe Impact Study on Brain Structure and Function, in a Population 45 to 75 Years Old
new study registeredNCT02198586The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Alzheimer Disease and Mixed Dementia
new study registeredNCT02187276Florbetapir Calibration to the Centiloid Scale
new study registeredNCT02120664Effects of Exercise Training in Patients With Mild Cognitive Impairment and Early Alzheimer's Disease
new study registeredNCT02119546Effect of Exercises Training in Patients With Mild Cognitive Impairment and Early Alzheimer's Disease
new study registeredNCT02074215A Study to Evaluate the Effect of Bexarotene on Beta-Amyloid and Apolipoprotein E Metabolism in Healthy Subjects
new study registeredNCT02061878A Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers to Evaluate Efficacy and Safety in the Treatment of Autosomal-Dominant Alzheimer's Disease (AD), Including a Placebo-Treated Non-Carrier Cohort
new study registeredNCT01998841Genistein as a Possible Treatment for Alzheimer's Disease.
new study registeredNCT01982578Sleep, Aging and Risk for Alzheimer's Disease
new study registeredNCT01962779Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset
new study registeredNCT01931566Inhalational Anesthesia and Precipitation of Dementia: is There a Link?
new study registeredNCT01903421Study to Evaluate Coconut Oil for Alzheimer's Disease
new study registeredNCT01883648Amyloid Accumulation After Mild Traumatic Brain Injury
new study registeredNCT01871610Bexarotene Amyloid Treatment for Alzheimer's Disease
new study registeredNCT01782742The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
new study registeredNCT01767909AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
new study registeredNCT01741194Evaluation of Effects of Multiple Dose Regimens of CHF 5074 on Potential Biomarkers of Neurodegeneration in Subjects With Mild Cognitive Impairment
new study registeredNCT01723670Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease
new study registeredNCT01677572Multi-modal Neuroimaging in Alzheimer's Disease IMAP+
new study registeredNCT01638949Efficacy of Pulsatile IV Insulin on Cognition and Amyloid Burden in Patients With Alzheimer's Disease
new study registeredNCT01636596Multi-modal Neuroimaging in Alzheimer's Disease
new study registeredNCT01554202Effects of Atomoxetine in Mild Cognitive Impairment
new study registeredNCT01522404A Study of the Safety, Tolerability, and Pharmacodynamics of MK-8931 in Participants With Alzheimer's Disease (MK-8931-010 AM1 [P07820 AM1])
new study registeredNCT01496170Mild Cognitive Impairment and Obstructive Sleep Apnea
new study registeredNCT01482351Risk Evaluation and Education for Alzheimer's Disease (REVEAL) IV
new study registeredNCT01434667[18F]MK-3328 as a Possible Novel Positron Emission Tomography (PET) Tracer for the Detection of Brain Amyloid Plaques (MK-3328-002)
new study registeredNCT01385033F-18-AV-45 Uptake, Spot Sign Presence and Cerebral Amyloid Angiopathy (CAA) in Primary Intracranial Hemorrhage (ICH)
new study registeredNCT01382849The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's Disease
new study registeredNCT01329536FluoroAv45 Imaging Research-in Alzheimer's Disease
new study registeredNCT01325259A Study of Alzheimer's Disease Using Magnetoencephalography (MEG) and the Synchronous Neural Interaction™ Test
new study registeredNCT01322373Safety and Tolerability of AFFITOPE AD03
new study registeredNCT01309763Study of Intravenous Immunoglobulin in Amnestic Mild Cognitive Impairment
new study registeredNCT01300728Alzheimer's Disease Neuroimaging Initiative 2
new study registeredNCT01231971AC-1204 Long-term Efficacy Response Trial (ALERT Protocol)
new study registeredNCT01211782A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's
new study registeredNCT01148498A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease Patients
new study registeredNCT00998764A Long-Term Safety And Tolerability Study Of Bapineuzumab In Alzheimer Disease Patients
new study registeredNCT00996918Early-onset and Late-onset Sporadic Alzheimer's Disease (AD)
new study registeredNCT00987090Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain
new study registeredNCT00857415Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease
new study registeredNCT00800709Mild Alzheimer''s Disease to Assess the of Extended Release Formulation of Rosiglitazone (RSG XR)
new study registeredNCT00688207Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients
new study registeredNCT00676143Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients
new study registeredNCT00667810The Impact of Lorazepam on Cognition in APOE e4 Carriers
new study registeredNCT00586430Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)
new study registeredNCT00575055Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)
new study registeredNCT00574132Risk Evaluation and Education for Alzheimer's Disease
new study registeredNCT00571025Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
new study registeredNCT00550420Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
new study registeredNCT00490568Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
new study registeredNCT00428090The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease
new study registeredNCT00381381Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease
new study registeredNCT00348309Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease
new study registeredNCT00348140Early Detection of Mild Cognitive Impairment in Individual Patients
new study registeredNCT00243451MIRAGE: Multi-Institutional Research in Alzheimer's Genetic Epidemiology
new study registeredNCT00239759Predictors of Cognitive Decline in Normal Aging
new study registeredNCT00094939PET Changes in Alzheimer's Disease (AD)
new study registeredNCT00094913Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II
new study registeredNCT00089882Treatment Study of Frontotemporal Dementia
new study registeredNCT00088751Brain Imaging in Alzheimer's Disease
new study registeredNCT00039702
No changes match the current filter. 0 high, 3 medium and 227 low-significance changes are in this snapshot — re-enable a level above to see them.